Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | NTHI | Common Stock | 340K | Mar 25, 2025 | Direct | ||||||
holding | NTHI | Common Stock | 488K | Mar 25, 2025 | See footnote 1. | F1 | |||||
holding | NTHI | Common Stock | 331K | Mar 25, 2025 | By HCWG LLC | F2 | |||||
holding | NTHI | Common Stock | 29.3K | Mar 25, 2025 | By Orion Biotech Inc. | F3 | |||||
holding | NTHI | Common Stock | 888K | Mar 25, 2025 | By NeuCen Biomedical Co. Ltd. | F4 |
Id | Content |
---|---|
F1 | Shares held by certain members of Reporting Person's immediate family. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |
F2 | Such shares are held by virtue of Reporting Person's beneficial ownership of HCWG LLC, a Delaware limited liability company ("HCWG"), which is the direct holder of such shares. Reporting Person owns 37.5% of HCWG. |
F3 | Shares held by Orion Biotech Inc. ("Orion"). Orion is owned in part by Reporting Person, who disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |
F4 | Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |